Market Place
Sourcing Support
Kamada Reports Q3 Growth & Raises Full-Year Profitability Guide
13 Nov 2024 //
GLOBENEWSWIRE
Kamada to Announce Q3 2024 Financials on Nov 13
06 Nov 2024 //
GLOBENEWSWIRE
Kamada to Present at the Stifel 2024 Healthcare Conference
04 Nov 2024 //
GLOBENEWSWIRE
Kamada Opens New Plasma Collection Site In Houston Texas
23 Sep 2024 //
GLOBENEWSWIRE
Kamada Reports Strong Q2 And H1 2024 Financials With 18% Growth And 68% Profit
14 Aug 2024 //
GLOBENEWSWIRE
Kamada To Announce Q2 And H1 2024 Results On August 14
07 Aug 2024 //
GLOBENEWSWIRE
Kamada Strong Q1 2024, Raises FY Guidance
08 May 2024 //
GLOBENEWSWIRE
Kamada Q1 2024 Results, Conference Call On May 8
01 May 2024 //
GLOBENEWSWIRE
Kamada Reports Strong Fiscal Year and Fourth Quarter 2023 Financial Results
06 Mar 2024 //
GLOBENEWSWIRE
Kamada Issues 2024 CEO Letter to Shareholders
06 Mar 2024 //
GLOBENEWSWIRE
Kamada to Announce Fourth Quarter and Fiscal Year 2023 Financial Results
28 Feb 2024 //
GLOBENEWSWIRE
Kedrion Announces An Extension Of The Distribution Agreement With Kamada
07 Dec 2023 //
PR NEWSWIRE
Kamada Announces its Largest Commercial Agreement
06 Dec 2023 //
GLOBENEWSWIRE
Kamada Reports Increase in Sales and Profitability in the Third Quarter
13 Nov 2023 //
GLOBENEWSWIRE
Kamada to Announce Third Quarter Financial Results
08 Nov 2023 //
GLOBENEWSWIRE
Kamada Provides Corporate Update on its Israel Operations
10 Oct 2023 //
GLOBENEWSWIRE
Kamada Announces Shareholder Approval and Planned Closing of $60 Million
30 Aug 2023 //
GLOBENEWSWIRE
Kamada Reports Strong Second Quarter and First Half 2023 Financial Results
16 Aug 2023 //
GLOBENEWSWIRE
Kamada to Announce Q2 and First Half Ended June 30, 2023 Financial Results
09 Aug 2023 //
GLOBENEWSWIRE
Kamada Announces Kedrion Exercised its Option for Two-Year Extension of KEDRAB® Distribution Agreement in the U.S.
12 Jul 2023 //
GLOBENEWSWIRE
Kamada Announces $60 Million Private Placement with FIMI Opportunity Funds
24 May 2023 //
GLOBENEWSWIRE
Kamada Announces CFO Chaime Orlev to Remain in Role & Appointment of Nir Livneh
24 May 2023 //
GLOBENEWSWIRE
Kamada Reports Strong First Quarter 2023 Financial Results
24 May 2023 //
GLOBENEWSWIRE
Kamada to Announce First Quarter 2023 Financial Results
17 May 2023 //
GLOBENEWSWIRE
Kamada Announces Receipt of Marketing Authorization for Glassia for Treatment
16 May 2023 //
GLOBENEWSWIRE
Kamada Reports Strong Fiscal Year and Fourth Quarter 2022 Financial Results
15 Mar 2023 //
GLOBENEWSWIRE
Kamada Issues 2023 CEO Letter to Shareholders
15 Mar 2023 //
GLOBENEWSWIRE
Kamada to Announce Fourth Quarter and Full Year 2022 Financial Results
09 Mar 2023 //
GLOBENEWSWIRE
Kamada Announces Submission of Application to FDA to Manufacture CYTOGAM
04 Jan 2023 //
GLOBENEWSWIRE
Kamada Announces Planned Transition of Chief Financial Officer
19 Dec 2022 //
GLOBENEWSWIRE
Kamada to market & distribute AcuCort’s drug Zeqmelit in Israel
25 Nov 2022 //
PHARMABIZ
Kamada Reports Strong Third Quarter Financial Results
22 Nov 2022 //
GLOBENEWSWIRE
Kamada Provides Update on Recent Progress Achieved in Ongoing Pivotal Ph3
07 Nov 2022 //
GLOBENEWSWIRE
Kamada to Present at the Credit Suisse 31st Annual Healthcare Conference
26 Oct 2022 //
GLOBENEWSWIRE
Kamada Awarded $22 Million Extension of Canadian Supply Tender
19 Oct 2022 //
BIOSPACE
Kamada Reports Second Quarter and First Half 2022 Financial Result
17 Aug 2022 //
GLOBENEWSWIRE
Kamada to Announce Q2 and First Half Ended June 30, 2022 Financial Results
10 Aug 2022 //
GLOBENEWSWIRE
Kamada Announces Resolution to Labor Strike at Company`s Manufacturing Facility
15 Jul 2022 //
GLOBENEWSWIRE
Kamada Announces $11.4 Million International VARIZIG Procurement Agreement
06 Jul 2022 //
GLOBENEWSWIRE
Kamada Strengthens Senior Leadership Team; Furthering Commitment
15 Jun 2022 //
GLOBENEWSWIRE
Kamada to Host a Virtual Analysts and Investors Meeting
01 Jun 2022 //
GLOBENEWSWIRE
Kamada Announces Expansion of Pivotal PIII Trial of Inhaled AAT
17 May 2022 //
GLOBENEWSWIRE
Kamada Reports First Quarter 2022 Financial Results
17 May 2022 //
GLOBENEWSWIRE
Kamada to Announce First Quarter Financial Results and Host Conference Call
11 May 2022 //
GLOBENEWSWIRE
Kamada Reports FY and Q4 2021 Financial Results
15 Mar 2022 //
GLOBENEWSWIRE
Kamada Issues 2022 CEO Letter to Shareholders
15 Mar 2022 //
GLOBENEWSWIRE
Kamada to Announce Q4 and Fiscal Year Ended December 31, 2021 Financial Results
02 Mar 2022 //
GLOBENEWSWIRE
Kamada Reports Third Quarter and First Nine Months of 2021 Financial
22 Nov 2021 //
GLOBENEWSWIRE
Kamada Announces Strategic Transformational Transaction Positioning the Company
22 Nov 2021 //
GLOBENEWSWIRE
Kamada to Announce Second Quarter and First Half 2021 Financial Results
05 Aug 2021 //
GLOBENEWSWIRE
Israel`s Kamada forges ahead with development of new anti-Covid immunoglobulin
19 Apr 2021 //
PRNEWSWIRE
Kamada Announces Amendment to GLASSIA® License Agreement with Takeda
07 Apr 2021 //
GLOBENEWSWIRE
Kamada Announces the Closing of the Acquisition of the FDA-Licensed Plasma
03 Mar 2021 //
BIOSPACE
Kamada Acquires FDA-Licensed Plasma Collection Center from Blood and Plasma
01 Feb 2021 //
BIOSPACE
Kedrion`s Partner, Kamada Ltd, Signs a Supply Agreement with the Israeli Health
21 Oct 2020 //
PRNEWSWIRE
Kamada Provides Update on 2021 GLASSIA Supply to Takeda
07 Oct 2020 //
GLOBENEWSWIRE
Kamada & Kedrion Biopharma Announce Results of First U.S. PMPediatric Trial
19 Aug 2020 //
PRNEWSWIRE
